Multiple myeloma and plasma cell disorders: update on diagnosis, prognosis, treatment, and supportive care
This supplement to JADPRO has been developed by members of the International Myeloma Foundation (IMF) Nurse Leadership Board.
This CE-certified supplement is jointly provided by
Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN
Cleveland Clinic Taussig Cancer Insitute
Tiffany Richards, PhD, ANP-BC, AOCNP
The University of Texas MD Anderson Cancer Center
This certified activity is supported by educational grants from AbbVie, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics; Legend Biotech; Oncopeptides, Inc.; Sanofi Genzyme; and Takeda Pharmaceuticals U.S.A., Inc.
Continuing Education
Continuing Education Information: Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care

Editorial
Introduction
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®
Grand Rounds
A Focus on Newly Diagnosed Multiple Myeloma
Kevin Brigle,(1) PhD, ANP, Daniel Verina,(2) DNP, RN, ACNP-BC, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Grand Rounds
A Focus on Relapsed Multiple Myeloma
Kimberly Noonan,(1) DNP, ANP-BC, AOCN®, Sandra Rome,(2) RN, MN, AOCN®, CNS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Grand Rounds
A Focus on Special Populations in Relapsed Multiple Myeloma
Mary Steinbach,(1) DNP, APRN, Kathleen Colson,(2) RN, BSN, BS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Grand Rounds
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
Donna Catamero, ANP-BC, OCN®, CCRC, Tiffany Richards, PhD, ANP-BC, AOCNP®, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Grand Rounds
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
Rebecca Lu, MS, FNP, and Tiffany Richards, PhD, ANP-BC, AOCNP®